基于2005版Caprini评分的个体化静脉血栓栓塞风险分层:外科患者药物预防获益与危害的Meta分析
该Meta分析纳入13项研究,评估基于Caprini评分个体化风险分层的 surgical 患者中药物预防VTE的获益与危害。结果显示未预防患者VTE风险从0.7%至10.7%有14倍差异,Caprini评分7-8分(OR 0.60,95%CI 0.37-0.97)和>8分(OR 0.41,95%CI 0.26-0.65)患者药物预防后VTE风险显著降低,≤6分患者(占75%)无显著获益,出血风险与评分无关。
要点
- Caprini评分≥7分外科患者药物预防VTE有显著获益
- Caprini评分≤6分患者占75%,药物预防无显著VTE风险降低
- 术后出血风险与Caprini评分无关联
核心结论
- 围术期VTE药物预防的获益仅见于Caprini评分≥7分的外科患者。
- 基于个体化VTE风险分层有助于确保药物预防仅用于合适患者并可能减少出血并发症。
研究设计与样本
- Meta分析,检索MEDLINE、EMBASE和Cochrane Library(CENTRAL)数据库。
- 纳入13项研究,其中11项(n=14,776)含VTE事件数据,8项(n=7,590)含临床相关出血数据。
- 采用随机效应模型进行Meta分析。
主要发现
- 未接受药物预防的外科患者中VTE风险从0.7%至10.7%,有14倍变异。
- Caprini评分7-8分患者药物预防后VTE风险显著降低(OR 0.60,95%CI 0.37-0.97)。
- Caprini评分>8分患者药物预防后VTE风险显著降低(OR 0.41,95%CI 0.26-0.65)。
- Caprini评分≤6分患者占总体75%,药物预防未显示显著VTE风险降低。
- 术后出血风险与Caprini评分无关联。
关键数值与推荐
- Caprini评分7-8分:药物预防VTE获益显著(OR 0.60,95%CI 0.37-0.97)。
- Caprini评分>8分:药物预防VTE获益显著(OR 0.41,95%CI 0.26-0.65)。
- Caprini评分≤6分:药物预防无显著VTE风险降低。
临床怎么用
- 对Caprini评分≥7分的外科患者考虑围术期药物预防VTE。
- 对Caprini评分≤6分患者不常规推荐药物预防,以避免不必要的出血风险。
局限性
- 多数患者接受了机械预防,可能影响结果解读。
- 纳入研究数量有限,部分分析样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We performed a meta-analysis to investigate benefits and harms of chemoprophylaxis among surgical patients individually risk stratified for venous thromboembolism (VTE) using Caprini scores. SUMMARY OF BACKGROUND DATA: Individualized VTE risk stratification may identify high risk surgical patients who benefit from peri-operative chemoprophylaxis. METHODS: MEDLINE, EMBASE, and the Cochrane Library (CENTRAL) databases were queried. Eligible studies contained data on postoperative VTE and/or bleeding events with and without chemoprophylaxis. Primary outcomes included rates of VTE and clinically relevant bleeding after surgical procedures, stratified by Caprini score. A meta-analysis was conducted using a random-effects model. RESULTS: Among 13 included studies, 11 (n = 14,776) contained data for VTE events and 8 (n = 7590) contained data for clinically relevant bleeding with and without chemoprophylaxis. The majority of patients received mechanical prophylaxis. A 14-fold variation in VTE risk (from 0.7% to 10.7%) was identified among surgical patients who did not receive chemoprophylaxis, and patients at increased levels of Caprini risk were significantly more likely to have VTE. Patients with Caprini scores of 7 to 8 [odds ratio (OR) 0.60, 95% confidence interval (95% CI) 0.37-0.97] and >8 (OR 0.41, 95% CI 0.26-0.65) had significant VTE risk reduction after surgery with chemoprophylaxis. Patients with Caprini scores ≤6 comprised 75% of the overall population, and these patients did not have a significant VTE risk reduction with chemoprophylaxis. No association between postoperative bleeding risk and Caprini score was identified. CONCLUSIONS: The benefit of peri-operative VTE chemoprophylaxis was only found among surgical patients with Caprini scores ≥7. Precision medicine using individualized VTE risk stratification helps ensure that chemoprophylaxis is used only in appropriate surgical patients and may minimize bleeding complications.
引用
- Pannucci CJ, Swistun L, MacDonald JK, et al. Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis. Ann Surg. 2017. PMID: 28106607. doi:10.1097/SLA.0000000000002126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。